Genotype and phenotype of COVID-19: Their roles in pathogenesis

Abstract

COVID-19 is a novel coronavirus with an outbreak of unusual viral pneumonia in Wuhan, China, and then pandemic. Based on its phylogenetic relationships and genomic structures the COVID-19 belongs to genera Betacoronavirus. Human Betacoronaviruses (SARS-CoV-2, SARS-CoV, and MERS-CoV) have many similarities, but also have differences in their genomic and phenotypic structure that can influence their pathogenesis. COVID-19 is containing singlestranded (positive-sense) RNA associated with a nucleoprotein within a capsid comprised of matrix protein. A typical CoV contains at least six ORFs in its genome. All the structural and accessory proteins are translated from the sgRNAs of CoVs. Four main structural proteins are encoded by ORFs 10, 11 on the one-third of the genome near the 3 0 -terminus. The genetic and phenotypic structure of COVID-19 in pathogenesis is important. This article highlights the most important of these features compared to other Betacoronaviruses.

Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)

“…In the case of SARS-cOV-2, the receptor is the angiotensin converting enzyme 2 (AcE2), which is found in large quantities in the respiratory tract and lung parenchyma (51)(52)(53)(54). The initial infection of SARS-cOV-2 occurs in the ciliary epithelial cells of the bronchi (55,56).…”

Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review

“…SARS-CoV-2 is an enveloped, non-segmented, single-stranded, positive-sense RNA virus belonging to the Coronaviridae family [4]. SARS-CoV-2 is a zoonotic virus not too dissimilar to the SARS-CoV outbreak of 2002 and the Middle East respiratory syndrome coronavirus of 2012 [5][6][7][8]. This novel coronavirus enters cells via binding of the viral surface spike protein to the angiotensin-converting enzyme (ACE) 2 protein [9].…”

ACE2 coding variants in different populations and their potential impact on SARS-CoV-2 binding affinity

“…Sequencing of ACE2 in patients with the most severe conditions in every population will also provide a more reliable conclusion. The sequencing projects will not only help us test the association between ACE2 variants and risk/severity of infection in certain populations, it will also allow more accurate analysis of variants for other host genes involved in the viral entry and pathogenicity 21 .…”